CatalYm announced the appointment of Scott Clarke as Chief Executive Officer. Mr. Clarke brings over two decades of executive leadership experience in driving company...
Oncocyte Corp, a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role,...
Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, announced that it has closed...
Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, announced the appointment of...
City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, announced the appointment of Andrew “Andy” Orth as chief executive...
